Which has higher valuation and earnings, GUTS or STRR?

Star Equity has higher revenue and earnings than Fractyl Health. Star Equity is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,348.53 -$140.95M -$1.29 N/A Star Equity $172.16M 0.24 -$5.92M -$2.63 N/A

Which has stronger earnings & valuation, STRR or CVRX?

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Star Equity $172.16M 0.24 -$5.92M -$2.63 N/A CVRx $56.65M 2.30 -$53.31M -$2.02 N/A

Is STRR or CVRX more profitable?

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% CVRx -89.14% -120.76% -48.38%

Is STRR or STIM more profitable?

Star Equity has a net margin of -4.18% compared to Neuronetics' net margin of -24.48%. Star Equity's return on equity of -4.04% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Star Equity -4.18% -4.04% -2.40% Neuronetics -24.48% -139.83% -27.13%

Star Equity (STRR) Competitors

$11.08 -0.07 (-0.58%)

As of 02:16 PM Eastern

Compare

STRR vs. STEX, RCEL, GUTS, CVRX, and STIM

Should you buy Star Equity stock or one of its competitors? MarketBeat compares Star Equity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Star Equity include Biosig Technologies (STEX), Avita Medical (RCEL), Fractyl Health (GUTS), CVRx (CVRX), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry.

How does Star Equity compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by company insiders. Comparatively, 31.6% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Star Equity has higher revenue and earnings than Biosig Technologies. Star Equity is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	3,581.46	-$462.77M	-$9.71	N/A
Star Equity	$172.16M	0.24	-$5.92M	-$2.63	N/A

Biosig Technologies presently has a consensus target price of $8.00, suggesting a potential upside of 915.23%. Star Equity has a consensus target price of $28.00, suggesting a potential upside of 152.59%. Given Biosig Technologies' higher possible upside, research analysts plainly believe Biosig Technologies is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

In the previous week, Biosig Technologies had 6 more articles in the media than Star Equity. MarketBeat recorded 6 mentions for Biosig Technologies and 0 mentions for Star Equity. Biosig Technologies' average media sentiment score of 0.48 beat Star Equity's score of 0.00 indicating that Biosig Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Biosig Technologies	Neutral
Star Equity	Neutral

Biosig Technologies has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

Biosig Technologies has a net margin of 0.00% compared to Star Equity's net margin of -4.18%. Star Equity's return on equity of -4.04% beat Biosig Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
Star Equity	-4.18%	-4.04%	-2.40%

Summary

Biosig Technologies beats Star Equity on 9 of the 16 factors compared between the two stocks.

How does Star Equity compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 31.6% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 2 more articles in the media than Star Equity. MarketBeat recorded 2 mentions for Avita Medical and 0 mentions for Star Equity. Avita Medical's average media sentiment score of 0.57 beat Star Equity's score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avita Medical	Positive
Star Equity	Neutral

Star Equity has higher revenue and earnings than Avita Medical. Star Equity is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	2.23	-$48.59M	-$1.57	N/A
Star Equity	$172.16M	0.24	-$5.92M	-$2.63	N/A

Avita Medical has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

Star Equity has a net margin of -4.18% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Star Equity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Star Equity	-4.18%	-4.04%	-2.40%

Avita Medical currently has a consensus target price of $7.25, suggesting a potential upside of 39.91%. Star Equity has a consensus target price of $28.00, suggesting a potential upside of 152.59%. Given Star Equity's higher probable upside, analysts plainly believe Star Equity is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

Summary

Avita Medical beats Star Equity on 10 of the 17 factors compared between the two stocks.

How does Star Equity compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Fractyl Health has a net margin of 0.00% compared to Star Equity's net margin of -4.18%. Star Equity's return on equity of -4.04% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Star Equity	-4.18%	-4.04%	-2.40%

Star Equity has higher revenue and earnings than Fractyl Health. Star Equity is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,348.53	-$140.95M	-$1.29	N/A
Star Equity	$172.16M	0.24	-$5.92M	-$2.63	N/A

Fractyl Health has a beta of 2.29, meaning that its share price is 129% more volatile than the broader market. Comparatively, Star Equity has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Fractyl Health presently has a consensus price target of $5.12, suggesting a potential upside of 569.28%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 152.59%. Given Fractyl Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Fractyl Health is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20

3.8% of Star Equity shares are held by institutional investors. 8.5% of Fractyl Health shares are held by insiders. Comparatively, 31.6% of Star Equity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Fractyl Health had 5 more articles in the media than Star Equity. MarketBeat recorded 5 mentions for Fractyl Health and 0 mentions for Star Equity. Fractyl Health's average media sentiment score of 0.48 beat Star Equity's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Neutral
Star Equity	Neutral

Summary

Fractyl Health beats Star Equity on 10 of the 17 factors compared between the two stocks.

How does Star Equity compare to CVRx?

Star Equity (NASDAQ:STRR) and CVRx (NASDAQ:CVRX) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

In the previous week, CVRx had 2 more articles in the media than Star Equity. MarketBeat recorded 2 mentions for CVRx and 0 mentions for Star Equity. Star Equity's average media sentiment score of 0.00 equaled CVRx'saverage media sentiment score.

Company	Overall Sentiment
Star Equity	Neutral
CVRx	Neutral

Star Equity currently has a consensus target price of $28.00, indicating a potential upside of 152.59%. CVRx has a consensus target price of $11.50, indicating a potential upside of 134.22%. Given Star Equity's higher probable upside, equities research analysts clearly believe Star Equity is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Star Equity has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

3.8% of Star Equity shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 31.6% of Star Equity shares are held by insiders. Comparatively, 18.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Star Equity has a net margin of -4.18% compared to CVRx's net margin of -89.14%. Star Equity's return on equity of -4.04% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
CVRx	-89.14%	-120.76%	-48.38%

Star Equity has higher revenue and earnings than CVRx. Star Equity is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.24	-$5.92M	-$2.63	N/A
CVRx	$56.65M	2.30	-$53.31M	-$2.02	N/A

Summary

Star Equity and CVRx tied by winning 7 of the 14 factors compared between the two stocks.

How does Star Equity compare to Neuronetics?

Star Equity (NASDAQ:STRR) and Neuronetics (NASDAQ:STIM) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, Neuronetics had 6 more articles in the media than Star Equity. MarketBeat recorded 6 mentions for Neuronetics and 0 mentions for Star Equity. Neuronetics' average media sentiment score of 0.50 beat Star Equity's score of 0.00 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Overall Sentiment
Star Equity	Neutral
Neuronetics	Positive

Star Equity presently has a consensus price target of $28.00, suggesting a potential upside of 152.59%. Neuronetics has a consensus price target of $4.00, suggesting a potential upside of 107.79%. Given Star Equity's higher possible upside, research analysts plainly believe Star Equity is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Star Equity	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.20
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Star Equity has higher revenue and earnings than Neuronetics. Star Equity is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Star Equity	$172.16M	0.24	-$5.92M	-$2.63	N/A
Neuronetics	$149.16M	0.90	-$39M	-$0.54	N/A

Star Equity has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market. Comparatively, Neuronetics has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

3.8% of Star Equity shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 31.6% of Star Equity shares are held by company insiders. Comparatively, 8.4% of Neuronetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Star Equity has a net margin of -4.18% compared to Neuronetics' net margin of -24.48%. Star Equity's return on equity of -4.04% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Star Equity	-4.18%	-4.04%	-2.40%
Neuronetics	-24.48%	-139.83%	-27.13%

Summary

Neuronetics beats Star Equity on 9 of the 17 factors compared between the two stocks.

Get Star Equity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STRR vs. The Competition

Export

Metric	Star Equity	DIVERSIFIED OPS Industry	Multi-Sector Sector	NASDAQ Exchange
Market Cap	$41.04M	$17.58B	$16.56B	$12.44B
Dividend Yield	N/A	4.67%	4.36%	9.39%
P/E Ratio	-4.22	28.98	24.84	24.19
Price / Sales	0.24	3.90	3.40	94.29
Price / Cash	17.61	46.33	44.54	47.25
Price / Book	0.58	4.23	3.81	6.26
Net Income	-$5.92M	$911.27M	$922.07M	$331.52M
7 Day Performance	-2.59%	-3.13%	-2.76%	-1.19%
1 Month Performance	-2.85%	-13.82%	-12.03%	-1.35%
1 Year Performance	442.80%	2.50%	1.41%	18.74%

Star Equity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STRR Star Equity	3.5056 of 5 stars	$11.09 -0.6%	$28.00 +152.6%	+469.5%	$41.04M	$172.16M	N/A	1,200
STEX Biosig Technologies	3.1947 of 5 stars	$0.81 -2.5%	$8.00 +891.9%	N/A	$146.62M	$40K	N/A	50	News Coverage Analyst Downgrade
RCEL Avita Medical	3.7862 of 5 stars	$4.73 +17.7%	$7.25 +53.3%	-0.6%	$145.58M	$72.35M	N/A	130
GUTS Fractyl Health	4.1582 of 5 stars	$0.91 +13.8%	$5.12 +462.6%	-56.4%	$144.37M	N/A	N/A	102	Gap Up High Trading Volume
CVRX CVRx	1.5681 of 5 stars	$5.27 +2.1%	$11.50 +118.2%	-40.4%	$139.87M	$56.65M	N/A	160	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STRR) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Star Equity (STRR) Competitors

STRR vs. STEX, RCEL, GUTS, CVRX, and STIM

How does Star Equity compare to Biosig Technologies?

Summary

How does Star Equity compare to Avita Medical?

Summary

How does Star Equity compare to Fractyl Health?

Summary

How does Star Equity compare to CVRx?

Summary

How does Star Equity compare to Neuronetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Star Equity (STRR) Competitors

STRR vs. STEX, RCEL, GUTS, CVRX, and STIM

How does Star Equity compare to Biosig Technologies?

Do insiders & institutionals hold more shares of STEX or STRR?

Which has stronger valuation and earnings, STEX or STRR?

Do analysts recommend STEX or STRR?

Does the media prefer STEX or STRR?

Which has more volatility & risk, STEX or STRR?

Is STEX or STRR more profitable?

Summary

How does Star Equity compare to Avita Medical?

Do insiders & institutionals hold more shares of RCEL or STRR?

Does the media favor RCEL or STRR?

Which has stronger valuation and earnings, RCEL or STRR?

Which has more risk & volatility, RCEL or STRR?

Is RCEL or STRR more profitable?

Do analysts prefer RCEL or STRR?

Summary

How does Star Equity compare to Fractyl Health?

Is GUTS or STRR more profitable?

Which has higher valuation and earnings, GUTS or STRR?

Which has more risk and volatility, GUTS or STRR?

Do analysts rate GUTS or STRR?

Do institutionals & insiders have more ownership in GUTS or STRR?

Does the media prefer GUTS or STRR?

Summary

How does Star Equity compare to CVRx?

Does the media refer more to STRR or CVRX?

Do analysts prefer STRR or CVRX?

Which has more risk and volatility, STRR or CVRX?

Do insiders and institutionals believe in STRR or CVRX?

Is STRR or CVRX more profitable?

Which has stronger earnings & valuation, STRR or CVRX?

Summary

How does Star Equity compare to Neuronetics?

Does the media refer more to STRR or STIM?

Do analysts rate STRR or STIM?

Which has stronger valuation and earnings, STRR or STIM?

Which has more volatility & risk, STRR or STIM?

Do institutionals and insiders have more ownership in STRR or STIM?

Is STRR or STIM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR vs. The Competition

Star Equity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools